Sekayombya Brian, Nahamya David, Garabedian Laura, Seru Morries, Trap Birna
Management Sciences for Health, Plot 15, Princess Anne Drive, Bugolobi, P.O. Box 71419, Kampala Uganda.
National Drug Authority, Plot 46 48 Lumumba Avenue, Kampala, Uganda.
J Pharm Policy Pract. 2019 Jan 22;12:2. doi: 10.1186/s40545-018-0161-y. eCollection 2019.
The National Drug Authority (NDA) inspects and certifies private and public sector pharmacies in Uganda using an indicator-based inspection tool that measures adherence to good pharmacy practices (GPP). 67 measures identify the situation in the domains of premises, dispensing quality, stores management, and operating requirements. Although the GPP measures are well-recognized and used internationally, little is known about their validity and reliability. The study aimed to assess validity, which measures agreement of GPP measures between a gold standard inspector and NDA inspector and inter-rater reliability (IRR), which measures agreement among NDA inspectors, of GPP measures.
We assessed validity and IRR by four teams of inspectors in eight government health facilities that represent three levels of care. Each team inspected two facilities, resulting in 24 total inspections. Each team comprised one central-level inspector, one district-level inspector, and one gold-standard inspector (i.e., a very experienced central-level inspector). We calculated median validity and IRR for each GPP measure, overall, indicator categorized as either critical, major, or minor, by domains, by the inspection decision (i.e., certified or not certified) and by adequatevalidity and IRR score (i.e., score ≥ 75%).
The median validity for all GPP measures was 69%, with 29 (43%) measures having an adequate validity of ≥75%. The median IRR for all GPP measures was 71%, with 31 (46%) having an adequate IRR measure of ≥75%. Validity did not differ significantly by indicator category, domain or level of care. Adequate IRR and validity score (≥75%) was lowest for critical measures, which are key determinants of the certification decision, scoring 20 and 40% respectively. District inspectors had lower median validity for critical indicators and premises and higher validity for store management. Compared to central inspectors, the validity of district inspectors'certification decisions was lower; in the eight facilities, three district inspectors agreed with gold standard inspector vs. all eight central inspectors.
Our findings question the validity and reliability of many GPP inspection measures, particularly critical measures that greatly impact certification decision. This study demonstrates the need for assessments of, and interventions to improve, validity and reproducibility of GPP measures and inspections.
乌干达国家药品管理局(NDA)使用一种基于指标的检查工具对该国公共和私营部门的药房进行检查和认证,该工具用于衡量对良好药房规范(GPP)的遵守情况。67项指标确定了场所、配药质量、库存管理和运营要求等领域的情况。尽管GPP指标在国际上得到广泛认可和应用,但对其有效性和可靠性却知之甚少。本研究旨在评估GPP指标在金标准检查员与NDA检查员之间的有效性(衡量两者之间的一致性)以及NDA检查员之间的评分者间信度(IRR,衡量检查员之间的一致性)。
我们由四组检查员在代表三个护理级别的八家政府医疗机构中评估有效性和IRR。每个小组检查两家机构,共进行24次检查。每个小组由一名中央级检查员、一名区级检查员和一名金标准检查员(即经验非常丰富的中央级检查员)组成。我们计算了每项GPP指标的中位数有效性和IRR,总体上,按指标类别(分为关键、主要或次要)、领域、检查决定(即认证或未认证)以及充分有效性和IRR评分(即评分≥75%)进行计算。
所有GPP指标的中位数有效性为69%,其中29项(43%)指标的有效性达到≥75%。所有GPP指标的中位数IRR为71%,其中31项(46%)的IRR测量值达到≥75%。有效性在指标类别、领域或护理级别方面没有显著差异。关键指标(认证决定的关键决定因素)的充分IRR和有效性评分(≥75%)最低,分别为20%和40%。区级检查员对关键指标和场所的中位数有效性较低,而对库存管理的有效性较高。与中央检查员相比,区级检查员认证决定的有效性较低;在这八家机构中,三名区级检查员与金标准检查员意见一致,而中央检查员则全部八名意见一致。
我们的研究结果对许多GPP检查指标的有效性和可靠性提出了质疑,尤其是对认证决定有重大影响的关键指标。本研究表明需要对GPP指标和检查的有效性及可重复性进行评估并采取干预措施加以改进。